Progress in myeloma at last.
出版信息
Br Med J. 1978 Jun 24;1(6128):1653-4.
Abstract
摘要
相似文献
1
Progress in myeloma at last.
Br Med J. 1978 Jun 24;1(6128):1653-4.
2
Vincristine in the treatment of multiple myeloma.
Haematologica. 1980 Oct;65(5):595-611.
3
[Chemotherapy of multiple myeloma. Review of the recent trials].
Recenti Prog Med. 1981 Aug;71(2):141-7.
4
[Therapeutic choices in myeloma].
Stomatol Mediterr. 1988 Oct-Dec;8(4):301-6.
5
Treatment of multiple myeloma in remission with anticancer drugs having cell cycle specific characteristics.
Cancer Treat Rep. 1977 May-Jun;61(3):381-8.
6
"Protracted pulse" chemotherapy for refractory myeloma: a preliminary report.
Eur J Haematol. 1990 Nov;45(5):274-5.
7
Polychemotherapy (COMP) treatment in myeloma patients. A preliminary report.
Haematologica. 1983 May-Jun;68(3):381-91.
8
Multiple myeloma: a therapeutic enigma.
Am J Clin Oncol. 1982 Feb;5(1):13-9.
9
Sequential therapy compared with combination therapy in multiple myeloma.
Arch Intern Med. 1975 Jan;135(1):163-71.
10
The current status and future prospects of treatment for multiple myeloma.
Clin Haematol. 1982 Feb;11(1):181-210.
本文引用的文献
1
Proceedings: Combination chemotherapy of multiple myeloma with alkeran, cytoxan, vincristine, prednisone, and BCNU.
Cancer. 1974 Feb;33(2):533-8. doi: 10.1002/1097-0142(197402)33:2<533::aid-cncr2820330231>3.0.co;2-z.
2
Plasma cell myeloma. An interpretive review.
Cancer. 1972 Dec;30(6):1588-94. doi: 10.1002/1097-0142(197212)30:6<1588::aid-cncr2820300626>3.0.co;2-y.
3
4
A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival.
Cancer. 1975 Sep;36(3):842-54. doi: 10.1002/1097-0142(197509)36:3<842::aid-cncr2820360303>3.0.co;2-u.
5
Expansion of the growth fraction in multiple myeloma with alkylating agents.
Blood. 1975 Jan;45(1):119-29.
6
Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol.
Am J Med. 1977 Dec;63(6):897-903. doi: 10.1016/0002-9343(77)90543-5.
7
Tumor size, sensitivity to therapy, and design of treatment schedules.
Cancer Treat Rep. 1977 Oct;61(7):1307-17.
8
Combination therapy for multiple myeloma.
Cancer. 1977 Dec;40(6):2765-71. doi: 10.1002/1097-0142(197712)40:6<2765::aid-cncr2820400602>3.0.co;2-x.
9
Radioimmunoassay for myeloma idiotype.
J Natl Cancer Inst. 1977 Jun;58(6):1553-5. doi: 10.1093/jnci/58.6.1553.
Zotero 插件